The Effects of EPA, DHA, and Aspirin Ingestion on Plasma Lysophospholipids and Autotaxin

Abstract Lysophophatidylcholine (LPC) and lysophosphatidic acid (LPA) are potent lysolipid mediators increasingly linked with atherosclerosis and inflammation. A current model proposing that plasma LPA is produced when LPC is hydrolyzed by the enzyme autotaxin has not been rigorously investigated in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Prostaglandins, leukotrienes and essential fatty acids leukotrienes and essential fatty acids, 2010-02, Vol.82 (2), p.87-95
Hauptverfasser:	Block, R.C, Duff, R, Lawrence, P, Kakinami, L, Brenna, J.T, Shearer, G.C, Meednu, N, Mousa, S, Friedman, A, Harris, W.S, Larson, Mark, Georas, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Advanced Basic Science Aspirin - pharmacology Autotaxin Biological and medical sciences Dietary Supplements Docosahexaenoic acid Docosahexaenoic Acids - pharmacology Eicosapentaenoic acid Eicosapentaenoic Acid - pharmacology Endocrinology & Metabolism Enzyme Activation - drug effects Female Fundamental and applied biological sciences. Psychology Humans Lipid Metabolism - drug effects Lysophosphatidic acid Lysophosphatidylcholine Lysophosphatidylcholines - blood Lysophospholipase D Lysophospholipids - blood Male Middle Aged Models, Biological Multienzyme Complexes - blood Phosphodiesterase I - blood Phosphoric Diester Hydrolases Pyrophosphatases - blood Vertebrates: endocrinology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!